![Table 1 from Insulin degludec (Tresiba ® ): Ultra-long basal insulin with less nocturnal hypoglycemia than glargine | Semantic Scholar Table 1 from Insulin degludec (Tresiba ® ): Ultra-long basal insulin with less nocturnal hypoglycemia than glargine | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e6ca9eeb157d08e3284e09b261ded4c12367e405/2-Table1-1.png)
Table 1 from Insulin degludec (Tresiba ® ): Ultra-long basal insulin with less nocturnal hypoglycemia than glargine | Semantic Scholar
![Insulin Degludec Tresiba Flex Touch at Rs 990/piece | Insulin Degludec in New Delhi | ID: 23393703473 Insulin Degludec Tresiba Flex Touch at Rs 990/piece | Insulin Degludec in New Delhi | ID: 23393703473](http://5.imimg.com/data5/SELLER/Default/2021/5/CZ/AU/AJ/11347047/insulin-degludec-tresiba-flex-touch.jpg)
Insulin Degludec Tresiba Flex Touch at Rs 990/piece | Insulin Degludec in New Delhi | ID: 23393703473
![Kairo, Ägypten, Oktober 4 2022: Tresiba FlexTouch Long Acting Insulin von Novo Nordisk Company und NovoRapid Solution zur Injektion in Kartuschen- Insulin Stockfotografie - Alamy Kairo, Ägypten, Oktober 4 2022: Tresiba FlexTouch Long Acting Insulin von Novo Nordisk Company und NovoRapid Solution zur Injektion in Kartuschen- Insulin Stockfotografie - Alamy](https://l450v.alamy.com/450vde/2kahwf0/kairo-agypten-oktober-4-2022-tresiba-flextouch-long-acting-insulin-von-novo-nordisk-company-und-novorapid-solution-zur-injektion-in-kartuschen-insulin-2kahwf0.jpg)
Kairo, Ägypten, Oktober 4 2022: Tresiba FlexTouch Long Acting Insulin von Novo Nordisk Company und NovoRapid Solution zur Injektion in Kartuschen- Insulin Stockfotografie - Alamy
![Tresiba (insulin degludec) for the Treatment of Type 1 and Type 2 Diabetes, USA - Clinical Trials Arena Tresiba (insulin degludec) for the Treatment of Type 1 and Type 2 Diabetes, USA - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2017/03/Image_3_-_Tresiba_insulin_degludec_for_the_Treatment_of_Type_1_and_Type_2_Diabetes1.jpg)